|
⚲
|
| Keyboard |
| Unninayar Kamalam
✚
|
|
|---|---|
| CIK # | 0001720065 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001720065] | |
| 4 | [0001720065] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Harvard Bioscience Inc | |
| Unninayar Kamalam | |
| Tetraphase Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Harvard Bioscience Inc HBIO
Common Stock
|
2019-03-07 | Grant | 37,995 | $0.00 | |
|
Harvard Bioscience Inc HBIO
Stock option (right to buy) · derivative
|
2019-03-07 | Grant | 91,139 | $0.00 | |
|
Harvard Bioscience Inc HBIO
Common Stock
|
2019-03-07 | Grant | 18,997 | $0.00 | |
|
Harvard Bioscience Inc HBIO
Common Stock
|
2019-01-01 | Tax withheld | 1,603 | $3.18 | 5,098 |
|
Harvard Bioscience Inc HBIO
Stock option (right to buy) · derivative
|
2018-11-26 | Grant | 44,585 | $0.00 | |
|
Harvard Bioscience Inc HBIO
Common Stock
|
2018-11-26 | Grant | 18,469 | $0.00 | |
|
Tetraphase Pharmaceuticals Inc TTPH
Restricted Stock Unit · derivative
|
2018-01-17 | Grant | 40,000 | $0.00 | |
|
Tetraphase Pharmaceuticals Inc TTPH
Employee Stock Option (Right to Buy) · derivative
|
2017-11-15 | Grant | 190,000 | $0.00 |